Mucormycosis and Rashes

Summary:

Rashes is found among people with Mucormycosis, especially for people who are male, 50-59 old.

The study analyzes which people have Rashes with Mucormycosis. It is created by eHealthMe based on reports of 14 people who have Mucormycosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Mucormycosis?

Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina) is found to be associated with 198 drugs and 689 conditions by eHealthMe. Check the latest studies of Mucormycosis.

What is Rashes?

Rashes (redness) is found to be associated with 3,713 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.



On Jul, 18, 2026

14 people who have Mucormycosis and Rashes are studied.

Would you have Rashes when you have Mucormycosis?

Gender of people who have Mucormycosis and experienced Rashes *:

  • female: 25 %
  • male: 75 %

Age of people who have Mucormycosis and experienced Rashes *:

  • 0-1: 0.0 %
  • 2-9: 7.69 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 15.38 %
  • 40-49: 0.0 %
  • 50-59: 46.15 %
  • 60+: 30.77 %

Common co-existing conditions for these people *:

  1. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 14.29%
  2. Type 2 Diabetes: 1 person, 7.14%
  3. Neutrophil Count Abnormal (abnormal number of neutrophil a type of blood cell): 1 person, 7.14%
  4. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 7.14%
  5. High Blood Pressure: 1 person, 7.14%
  6. Depression: 1 person, 7.14%
  7. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.14%
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 7.14%
  9. Bacterial Infection: 1 person, 7.14%
  10. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 7.14%

Common drugs taken by these people *:

  1. Ambisome: 9 people, 64.29%
  2. Posaconazole: 2 people, 14.29%
  3. Cubicin: 2 people, 14.29%
  4. Sirolimus: 2 people, 14.29%
  5. Mycophenolate Mofetil: 2 people, 14.29%
  6. Noxafil: 2 people, 14.29%
  7. Cresemba: 2 people, 14.29%
  8. Furosemide: 1 person, 7.14%
  9. Famotidine: 1 person, 7.14%
  10. Emend: 1 person, 7.14%

Common symptoms for these people *:

  1. Renal Impairment (severely reduced kidney function): 4 people, 28.57%
  2. Escherichia Infection (bacterial infection by escherichia coli): 4 people, 28.57%
  3. Hypotension (abnormally low blood pressure): 4 people, 28.57%
  4. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 3 people, 21.43%
  5. Fever: 3 people, 21.43%
  6. Coughing Up Blood: 3 people, 21.43%
  7. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 21.43%
  8. Leukopenia (less number of white blood cells in blood): 3 people, 21.43%
  9. Cardiac Arrest: 3 people, 21.43%
  10. Blood Immunoglobulin G Decreased: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rashes?

- Check whether Rashes is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Rashes:

All the conditions that are associated with Rashes:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Rashes and Mucormycosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: